Bill

Bill > SB68


WI SB68

WI SB68
The prescription drug monitoring program. (FE)


summary

Introduced
02/24/2025
In Committee
03/18/2025
Crossed Over
03/18/2025
Passed
03/21/2025
Dead
Signed/Enacted/Adopted
03/28/2025

Introduced Session

2025-2026 Regular Session

Bill Summary

AN ACT to amend 961.385 (2) (cs) 1., 961.385 (5) (b) and 961.385 (6) (a) of the statutes; relating to: the prescrip- tion drug monitoring program.

AI Summary

This bill extends two key provisions related to the Prescription Drug Monitoring Program (PDMP), a system that tracks prescription medications to help prevent drug misuse and potential overdoses. First, the bill continues the requirement that healthcare practitioners review a patient's prescription records in the PDMP before issuing a new prescription order, extending this mandate from April 1, 2025, to April 1, 2030. Second, the bill prolongs the Controlled Substances Board's obligation to conduct quarterly reviews of the PDMP, comparing actual program outcomes to projected outcomes, by extending the review requirement from October 30, 2025, to October 30, 2030. These extensions will help ensure continued oversight and monitoring of prescription drug dispensing, potentially allowing healthcare providers and regulatory bodies to maintain valuable insights into prescription drug usage patterns and effectiveness of the monitoring program.

Committee Categories

Health and Social Services

Sponsors (2)

Last Action

Published 3-29-2025 (on 03/28/2025)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...